β-elemene combined with temozolomide in treatment of brain glioma

β-elemene combined with temozolomide in treatment of brain glioma

Temozolomide (TMZ) is a widely used chemotherapeutic agent for malignant glioma. β-Elemene has been reported to have the ability of passing through the blood-brain barrier and reverse multidrug resistance. In the present study, transport of drugs through the in vitro blood-brain barrier (BBB) model...

Full description

Bibliographic Details
Main Authors:	Xiaomin Zhang, Yidan Chen, Ju Yao, Yingxin Zhang, Mengying Li, Bo Yu, Kaifeng Wang
Format:	Article
Language:	English
Published:	Elsevier 2021-12-01
Series:	Biochemistry and Biophysics Reports
Subjects:	β-elemene Temozolomide Combination Glioma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405580821002387

Similar Items

Second generation β-elemene nitric oxide derivatives with reasonable linkers: potential hybrids against malignant brain glioma
by: Renren Bai, et al.
Published: (2022-12-01)

KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation
by: Guo Yu, et al.
Published: (2016-04-01)

Effect of temozolomide and methylprednisolone on the radiosensitivity in radiotherapy of human brain glioma cells
by: Yu LI, et al.
Published: (2011-06-01)

The Paired Siglecs in Brain Tumours Therapy: The Immunomodulatory Effect of Dexamethasone and Temozolomide in Human Glioma In Vitro Model
by: Przemyslaw Wielgat, et al.
Published: (2021-02-01)

Temozolomide Chronotherapy in Glioma: A Systematic Review
by: Jason L. Jia, et al.
Published: (2023-02-01)

Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells
by: Shigeo Ohba, et al.
Published: (2021-05-01)

Combinative effects of β-elemene and propranolol on the proliferation, migration, and angiogenesis of hemangioma
by: Zhenyu Wang, et al.
Published: (2023-07-01)

Temozolomide-Induced Changes in Gut Microbial Composition in a Mouse Model of Brain Glioma
by: Li XC, et al.
Published: (2021-04-01)

Down-Regulation of CEND1 Expression Contributes to The Progression and Temozolomide Resistance of Glioma
by: Houjun Zhou, et al.
Published: (2023-04-01)

A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
by: Zhifang Hu, et al.
Published: (2020-06-01)

Temozolomide with Radiation Therapy in High Grade Brain Gliomas: Pharmaceuticals Considerations and Efficacy;A Review Article
by: Demetrios Chaldeopoulos, et al.
Published: (2009-04-01)

Sitagliptin inhibits the survival, stemness and autophagy of glioma cells, and enhances temozolomide cytotoxicity
by: Fangting You, et al.
Published: (2023-06-01)

Difference in the Inhibitory Effect of Temozolomide on TJ905 Glioma Cells and Stem Cells
by: Feng Jin, et al.
Published: (2017-09-01)

Dissolvable hyaluronic acid microneedles loaded with β-Elemene for the treatment of psoriasis
by: Chun Wang, et al.
Published: (2022-11-01)

Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas
by: Jiapeng Liu, et al.
Published: (2024-04-01)

SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide
by: Xu Wang, et al.
Published: (2022-08-01)

Progress of temozolomide in the treatment of recurrent high-grade gliomas
by: Jin-duo LI, et al.
Published: (2013-12-01)

β-Elemene: Mechanistic Studies on Cancer Cell Interaction and Its Chemosensitization Effect
by: Ziyu Jiang, et al.
Published: (2017-03-01)

Identification and verification of the temozolomide resistance feature gene DACH1 in gliomas
by: Qiang Gu, et al.
Published: (2023-03-01)

Engrailed 2 (EN2) acts as a glioma suppressor by inhibiting tumor proliferation/invasion and enhancing sensitivity to temozolomide
by: Tengfei Li, et al.
Published: (2020-03-01)

A MRI-based radiomics model for predicting the response to anlotinb combined with temozolomide in recurrent malignant glioma patients
by: Yurong Li, et al.
Published: (2023-08-01)

Beneficial effect of β-elemene alone and in combination with hyperbaric oxygen in traumatic brain injury by inflammatory pathway
by: Meng Xiangen, et al.
Published: (2018-06-01)

Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV
by: Susan G. R. McDuff, et al.
Published: (2020-01-01)

Gut microbiota mediated the individualized efficacy of Temozolomide via immunomodulation in glioma
by: Xiaoying Hou, et al.
Published: (2023-03-01)

Application progress of temozolomide in clinical tumor chemotherapy
by: Cheng ZHONG, et al.
Published: (2013-12-01)

β-Elemene Reverses Chemoresistance of Breast Cancer via Regulating MDR-Related MicroRNA Expression
by: Jun Zhang, et al.
Published: (2014-11-01)

Long-term adjuvant administration of temozolomide impacts serum ions concentration in high-grade glioma
by: Liyun Zhong, et al.
Published: (2022-02-01)

Knockdown ATG4C inhibits gliomas progression and promotes temozolomide chemosensitivity by suppressing autophagic flux
by: Zhi-peng Wen, et al.
Published: (2019-07-01)

Temozolomide and oral etoposide in children with recurrent malignant brain tumors
by: Antonio Ruggiero, et al.
Published: (2020-06-01)

Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1–Survivin axis
by: Jun-Hai Tang, et al.
Published: (2019-12-01)

Novel diagnostic and therapeutic approaches to malignant glioma
by: Swiss Medical Weekly
Published: (2011-05-01)

Preparation, characterization, pharmacokinetics and anticancer effects of PEGylated β-elemene liposomes
by: Bingtao Zhai, et al.
Published: (2020-02-01)

The efficacy of targeted therapy combined with radiotherapy and temozolomide-based chemotherapy in the treatment of glioma: A systemic review and meta-analysis of phase II/III randomized controlled trials
by: Yifan Ma, et al.
Published: (2023-01-01)

Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells
by: Chung-Ching Chio, et al.
Published: (2018-04-01)

MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide
by: Rui Chen, et al.
Published: (2016-06-01)

Study on mechanism of thalidomide combined with temozolomide to suppress proliferation of U251 glioma cell in vitro
by: Song GAO, et al.
Published: (2010-10-01)

Long non-coding RNA in glioma: novel genetic players in temozolomide resistance
by: Jungwook Roh, et al.
Published: (2023-12-01)

MiR‐634 sensitizes glioma cells to temozolomide by targeting CYR61 through Raf‐ERK signaling pathway
by: Zhigang Tan, et al.
Published: (2018-03-01)

Combination chemoradiotherapy with temozolomide, vincristine, and interferon-β might improve outcomes regardless of O6-methyl-guanine-DNA-methyltransferase (MGMT) promoter methylation status in newly glioblastoma
by: Kenichiro Asano, et al.
Published: (2021-07-01)

Cranial Spinal Spreading of Canine Brain Gliomas after Hypofractionated Volumetric-Modulated Arc Radiotherapy and Concomitant Temozolomide Chemotherapy: A Four-Case Report
by: Gaetano Urso, et al.
Published: (2022-09-01)